257 related articles for article (PubMed ID: 9764963)
1. Population pharmacokinetics of gentamicin in patients with cancer.
Rosario MC; Thomson AH; Jodrell DI; Sharp CA; Elliott HL
Br J Clin Pharmacol; 1998 Sep; 46(3):229-36. PubMed ID: 9764963
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
Xuan D; Nicolau DP; Nightingale CH
Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
[TBL] [Abstract][Full Text] [Related]
4. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Matthews I; Kirkpatrick C; Holford N
Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of four once-daily aminoglycoside dosing nomograms.
Wallace AW; Jones M; Bertino JS
Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
[TBL] [Abstract][Full Text] [Related]
8. A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing.
Llanos-Paez CC; Staatz CE; Lawson R; Hennig S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533244
[TBL] [Abstract][Full Text] [Related]
9. Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.
Conil JM; Georges B; Ruiz S; Rival T; Seguin T; Cougot P; Fourcade O; Pharmd GH; Saivin S
Br J Clin Pharmacol; 2011 Jan; 71(1):61-71. PubMed ID: 21143502
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of gentamicin and dosing optimization for infants.
Medellín-Garibay SE; Rueda-Naharro A; Peña-Cabia S; García B; Romano-Moreno S; Barcia E
Antimicrob Agents Chemother; 2015 Jan; 59(1):482-9. PubMed ID: 25385111
[TBL] [Abstract][Full Text] [Related]
11. Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.
Germovsek E; Kent A; Metsvaht T; Lutsar I; Klein N; Turner MA; Sharland M; Nielsen EI; Heath PT; Standing JF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4869-77. PubMed ID: 27270281
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of gentamicin in premature newborns.
García B; Barcia E; Pérez F; Molina IT
J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.
Demczar DJ; Nafziger AN; Bertino JS
Antimicrob Agents Chemother; 1997 May; 41(5):1115-9. PubMed ID: 9145878
[TBL] [Abstract][Full Text] [Related]
14. Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children.
Liu X; Smits A; Wang Y; Renard M; Wead S; Kagan RJ; Healy DP; De Cock P; Allegaert K; Sherwin CMT
Ther Drug Monit; 2019 Feb; 41(1):44-52. PubMed ID: 30299427
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya.
Thomson AH; Kokwaro GO; Muchohi SN; English M; Mohammed S; Edwards G
Br J Clin Pharmacol; 2003 Jul; 56(1):25-31. PubMed ID: 12848772
[TBL] [Abstract][Full Text] [Related]
16. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetic Analysis of Gentamicin in Pediatric Extracorporeal Membrane Oxygenation.
Moffett BS; Morris J; Galati M; Munoz FM; Arikan AA
Ther Drug Monit; 2018 Oct; 40(5):581-588. PubMed ID: 29957666
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.
Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Wong FA; Corrado M
Antimicrob Agents Chemother; 1998 May; 42(5):1098-104. PubMed ID: 9593134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
